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Tumor Size Predicts Vascular Invasion and Histologic
Grade: Implications for Selection of Surgical Treatment
for Hepatocellular Carcinoma
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Vascular invasion and high histologic grade predict poor
outcome after surgical resection or liver transplantation
for hepatocellular carcinoma (HCC). Despite the known
association between tumor size and vascular invasion, a
proportion of patients with large tumors can be treated
surgically with excellent outcomes. Clariﬁcation of the
association between tumor size, histologic grade, and vas-
cular invasion has implications for patient selection for
resection and transplantation. The objective of this study
was to examine the relationship between HCC tumor size
and microscopic (occult) vascular invasion and histologic
grade in a multicenter international database of 1,073
patients who underwent resection of HCC. The incidence
of microscopic vascular invasion increased with tumor
size (<3 cm, 25%; 3.1-5 cm, 40%; 5.1-6.5 cm, 55%;>6.5
cm, 63%) (P < 0.005). Both size and number of tumors
were important factors predicting vascular invasion.
Among all patients with tumors 5.1 to 6.5 cm, micro-
scopic vascular invasion was present in 55% compared
with 31% for all patients with tumors 5 cm or smaller
(P < 0.001). Among patients with solitary tumors only,
microscopic vascular invasion was signiﬁcantly more
common in tumors measuring 5.1 to 6.5 cm (41%) com-
pared with 27% of tumors 5 cm or smaller (P < 0.003).
Tumor size also predicted histologic grade: 36% of
tumors 5 cm or smaller were high grade, compared with
54% of lesions 5.1 to 6.5 cm (P  0.01). High histologic
grade, an alpha-fetoprotein level of at least 1000 ng/mL,
and multiple tumor nodules each predicted occult vas-
cular invasion in tumors larger than 5 cm. The high
incidence of occult vascular invasion and advanced his-
tologic grade in HCC tumors larger than 5 cm, as well
as biologic predictors of poor prognosis, should be
considered before criteria for transplantation are
expanded to include these patients. (Liver Transpl
2005;11:1086-1092.)
Hepatic resection and liver transplantation areaggressive, extirpative approaches to the treat-
ment of selected patients for hepatocellular carcinoma
(HCC) and are the only known potentially curative
treatment options for this disease. Resection and trans-
plantation are largely complimentary, not competing,
treatments—resection for patients with preserved liver
function and transplantation for patients with compro-
mised liver function. Within each group, selection of
patients for surgical therapy is currently based on mor-
phologic criteria such as size, number of tumors, and
degree of underlying liver disease.
After resection, long-term survival can be expected
in patients with solitary tumors regardless of size, espe-
cially when underlying ﬁbrosis is minimal.1 In fact, size
has no signiﬁcant impact on survival when microscopic
vascular invasion is absent, as survival after resection of
T1 tumors larger than 10 cm in diameter is similar to
survival following resection of T1 tumors less than 5
cm.1 Similarly, long-term survival can be expected
when multiple tumors without vascular invasion are
completely resected.1
The establishment of strict morphologic criteria has
signiﬁcantly impacted the outcome after liver trans-
plantation for HCC. Before the adoption of these cri-
teria for transplantation, results with liver transplanta-
tion were poor. Recurrence rates ranged from 60% to
70%,2,3 and the 5-year survival rate was less than
30%.4,5 Since the implementation of more stringent
selection criteria, survival rates after liver transplanta-
tion have been similar to those after resection for
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patients without cirrhosis who have lesions of similar
stage.6,7 Speciﬁcally, survival data obtained fromMilan
and Barcelona revealed 4-year survival rates of 75%
after liver transplantation,8,9 based on careful selection
of patients with speciﬁc morphologic criteria: only
patients with HCC and cirrhosis who had three or
fewer tumor nodules that were 3 cm or less inmaximum
diameter or a single tumor 5 cm or less and no clinically
apparent signs of vascular invasion were considered
acceptable for transplantation.10 Although these arbi-
trary criteria were determined based on the small series
from Mazaferro et al.,9 no patients in that series had
evidence of microscopic vascular invasion in the
explanted tumor specimens, which may not represent
the spectrum of tumors treated based on these criteria.
The recognition, however, that tumor size and tumor
number impact outcome has led to the adoption of
these criteria worldwide for liver transplantation.
Subsequent studies1,11,12 have shown that vascular
invasion—macroscopic or microscopic—is one of the
strongest predictors of tumor recurrence after liver
transplantation. Llovet et al.8 reported that microscopic
vascular invasion detected at pathologic examination of
the explant specimen was associated with no disease-
free survivors at 3 years, whereas 94% of patients with-
out macro- or microscopic vascular invasion were dis-
ease-free after 3 years.
Since microscopic invasion cannot be determined
preoperatively, tumor grade has been investigated as a
possible surrogate marker of microscopic vascular inva-
sion. In an analysis of tumors less than 5 cm, Esnaola et
al.13 reported that tumor size greater than 4 cm and
high-tumor grade predicted microscopic vascular inva-
sion in patients with HCC who were candidates for
liver transplantation. Others have also shown that
tumor grade is an important prognostic factor after liver
transplantation.14-16 In fact, several studies have
directly correlated tumor grade with prognosis after
resection or transplantation.17-20 For example, Jonas et
al.14 reported that the 5-year survival rate after liver
transplantation for HCC was 84% in patients with
well-differentiated tumors, compared with only 41% in
patients with poorly differentiated tumors.
Currently, patients with solitary tumors without evi-
dence of major vascular invasion are considered for
surgical treatment based on the presence or absence of
underlying liver disease. Absent underlying liver dis-
ease, major resection is considered appropriate. In the
presence of severe cirrhosis, transplantation has been
proposed for selected patients with solitary tumors up
to 6.5 cm in maximal diameter.10,21 There is concern,
however, that allocation of organs to patients with large
tumors (5 cm) will negatively impact outcome
because of the increasing incidence of (microscopic)
vascular invasion and advanced histologic grade in
tumors as size increases. Using both the Milan criteria9
(5-cm cutoff for solitary tumors) and the recent Uni-
versity of California San Francisco10 proposal (6.5-cm
cutoff for solitary tumors) as a guideline for the analysis,
the objective of the current study was to examine the
association between tumor size, tumor number, histo-
logic grade, and the incidence of vascular invasion in
HCC. More importantly, we sought to identify predic-
tors of microscopic vascular invasion in patients with
large (5 cm) HCC.
Patients and Methods
Between January 1986 and September 2000, 1073 patients
with HCC underwent resection at ﬁve major hepatobiliary
centers: The University of Texas M. D. Anderson Cancer
Center (Houston, TX),Mayo Clinic (Rochester, MN), Beau-
jon Hospital (Paris, France), Kyoto University Graduate
School of Medicine (Kyoto, Japan), and Queen Mary Hospi-
tal (Hong Kong, China). The clinical data were reviewed on
site by J.N.V., D.M.N., and R.T.P., and the pathologic resec-
tion specimens were reviewed on site by G.Y.L. and I.O.N.
Only patients with HCC who had no clinical, radiographic,
or intraoperative evidence of extrahepatic disease and who
underwent an attempt at curative resection were included in
the study. The following data were collected for each patient:
demographics; laboratory data (alpha-fetoprotein [AFP] level
and hepatitis serology); tumor size, number, histologic grade,
and location; presence of vascular invasion (major and micro-
scopic); and operative ﬁndings. Data were recorded as follows:
clinical features, present or absent; age, younger than 60 years
vs. 60 years or older; AFP level, less than 1000 ng/mL vs. 1000
ng/mL or greater; and tumor number, single vs. multiple.
Tumor size was deﬁned as the largest diameter of the tumor in
the resected specimen. In patients with multiple tumors, the
largest lesion was used as the index lesion. Tumor grade was
assessed using the nuclear grading scheme outlined by
Edmondson and Steiner, with tumor grade categorized as
low, intermediate, or high.22 Tumor grade was deﬁned by the
poorest degree of differentiation identiﬁed within the tumor
upon pathologic analysis of the entire resected specimen. The
degree of ﬁbrosis of the hepatic parenchyma was graded
according to the established classiﬁcation scheme of Ishak et
al.23: Ishak grade 0, no ﬁbrosis; Ishak grade 1 or 2, minimal
ﬁbrosis; Ishak grade 3 or 4, incomplete bridging ﬁbrosis; Ishak
grade 5 or 6, complete ﬁbrosis or cirrhosis. Vascular invasion
was deﬁned by the ﬁndings on ﬁnal pathologic analysis.
Microscopic vascular invasion was deﬁned as the presence of
tumor emboli within the central vein, the portal vein, or large
capsular vessels or involvement of the lobar or segmental
branches of the portal vein or the hepatic veins.1,24 Major
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vascular invasion was deﬁned as gross invasion of the right or
left main branches of the portal vein or the hepatic veins.25
All data are presented as percentages of patients or the
median value. Statistical analyses were performed using uni-
variate tests (chi square). Where reported, multivariate anal-
yses were performed by entering factors that appeared to be
signiﬁcant on univariate analysis (P  0.10) into a Cox pro-
portional hazards model to test for signiﬁcant effects while
adjusting for multiple factors simultaneously. A P-value 
0.05 was considered signiﬁcant.
Results
Table 1 shows the clinicopathologic features of the
1073 patients in the study. There were 805 men and
268 women, for a male-to-female ratio of 3:1. The
median patient age was 59 years (range, 5-88 years).
The majority of patients had solitary tumors, and the
median tumor size was 6.0 cm (range, 0.3-27.0 cm).
Most tumors were intermediate or high grade. Only
15% of patients had low-grade tumors. A minority of
patients had cirrhosis (25%).
The overall incidence of major vascular invasion was
9.4% (n 101) and the incidence of microscopic vas-
cular invasion was 49% (n  528). As tumor size
increased, the incidence of major vascular invasion
increased: 3 cm or smaller, 3%; 3.1 to 5 cm, 4%; 5.1 to
6.5 cm, 10%; larger than 6.5 cm, 16% (P  0.001).
Similarly, the incidence of microscopic vascular inva-
sion increased with tumor size as follows: 3 cm or
smaller, 25%; 3.1 to 5 cm, 40%; 5.1 to 6.5 cm, 55%;
larger than 6.5 cm, 63% (P  0.005) (Fig. 1).
The rates of microscopic and major vascular inva-
sion in patients with either solitary or multiple tumors
are shown in Table 2. Patients with multiple tumors
with a maximal tumor size larger than 6.5 cm had a
higher incidence of microscopic vascular invasion com-
pared to patients who had solitary tumors of a similar
size (Table 2). Patients who had solitary tumors mea-
suring 6.5 cm or smaller, however, had the same inci-
dence of microscopic vascular invasion (29%) as
patients who had less than three tumor nodules, none of
which measured greater than 5 cm in size. The inci-
dence of microscopic vascular invasion was 31% for all
tumors measuring 5 cm or less, compared with 55% for
all tumors measuring 5.1 to 6.5 cm (P  0.001) (Fig.
2). Of note, solitary tumors measuring 5 cm or less had
an incidence of microscopic vascular invasion of 27%
compared with 41% for solitary tumors measuring 5.1
to 6.5 cm (P  0.003). Solitary tumors measuring
greater than 6.5 cm had an incidence of microscopic
vascular invasion of 58% (P  0.005 compared with
solitary lesionsmeasuring 5 cm or less or comparedwith
solitary tumors measuring 5.1 to 6.5 cm).
Tumor size was also associated with histologic grade.
Table 1. Clinical and Pathologic Features of Patients
(n  1073)
Variable
Number of Patients
(%)
Age, yrs
60 546 (51)
60 527 (49)
Sex
Male 805 (75)
Female 268 (25)
Child-Turcotte-Pugh classiﬁcation*
A 849 (89)
B 100 (10.5)
C 1 (0.5)
Alpha-fetoprotein level*
1000 ng/mL 688 (71)
1000 ng/mL 283 (29)
Tumor size
3 cm 260 (24)
3.1–5.0 cm 228 (21)
5.1–6.5 cm 89 (9)
6.5 cm 496 (46)
Tumor number
Single 877 (82)
Multiple 196 (18)
Edmondson-Steiner grade
Low (grade I) 161 (15)
Intermediate (grade II) 435 (41)
High (grade III or IV) 477 (44)
Ishak score
Ishak 1–4 804 (75)
Ishak 5–6 269 (25)
Hepatitis status*
Hepatitis negative 254 (24)
Hepatitis B 584 (54)
Hepatitis C 155 (15)
Co-infection 75 (7)
* Information not available for all patients.
Figure 1. Incidence of microscopic and major vascular
invasion stratiﬁed by tumor size.
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As tumor size increased, the incidence of low-grade
tumors decreased and the incidence of high-grade
tumors increased. Overall, tumors 5 cm or smaller were
more frequently low grade (19% for tumors5 cm vs.
12% for tumors 5 cm) (P  0.006), and tumors
larger than 5 cmwere more frequently high grade (37%
for tumors 5 cm vs. 47% for tumors 5 cm) (P 
0.004). The incidence of high-grade tumors was 36%
for tumors 5 cm or smaller, compared with 54% for
tumors 5.1 to 6.5 cm (P 0.01). In addition, large (5
cm) tumors that were intermediate- or high-grade had a
signiﬁcantly greater likelihood of being associated with
microscopic vascular invasion compared to small (5
cm) intermediate- or high-grade tumors or large ( 6.5
cm) low-grade tumors (each P  0.05 vs.  5 cm
intermediate- or high-grade tumors) (Fig. 3). Whereas
only 30% of patients with intermediate- or high-grade
tumors measuring 5 cm or less had evidence of micro-
scopic vascular invasion, the rate of microscopic vascu-
lar invasion was 66% in intermediate- or high-grade
tumors measuring 5.1 to 6.5 cm (P  0.001).
To identify predictors of microscopic vascular inva-
sion in patients with HCC larger than the current 5-cm
size limit speciﬁed by the Milan criteria, a separate
analysis was performed. A total of 486 patients were
excluded from this separate analysis because of tumor
size 5 cm or less, and 85 patients were excluded because
of the presence of major vascular invasion. Of the 502
patients in this analysis (all with tumors 5 cm, none
with major vascular invasion), 287 (57%) had micro-
scopic invasion on pathologic review. Statistical analysis
revealed several factors that were signiﬁcantly associated
with microscopic vascular invasion in tumors larger
than 5 cm.On univariate analysis, high histologic grade
(Table 3), preoperative AFP level of at least 1000
ng/mL, the presence of tumor invasion of an adjacent
organ, multiple tumor nodules, and tumor size were
each associated with the presence of microscopic vascu-
lar invasion. Patients with a preoperative AFP level of at
least 1,000 ng/mLweremore likely to havemicroscopic
vascular invasion on the ﬁnal pathology review (64%)
than were patients with an AFP level of less than 1000
ng/mL (43%) (P 0.001). Similarly, microscopic vas-
cular invasion was more common in tumors that were
Figure 3. Histologic grade stratiﬁed by tumor size and
rate of microscopic vascular invasion.
Table 2. Association of Vascular Invasion and Tumor Number Stratiﬁed by Tumor Size
Tumor Size
Microscopic Vascular
Invasion (%)
P Value
Major Vascular Invasion (%)
P ValueSolitary Multiple* Solitary Multiple*
3 cm 28 42 0.38 3 8 0.12
3.1–5.0 cm 39 42 0.87 3 13 0.02
5.1–6.5 cm 54 59 0.24 5 22 0.04
6.5 cm 58 76 0.03 14 20 0.09
* For multiple tumors, tumor size refers to the dimension of the largest single lesion.
Figure 2. (A) The incidence of microscopic vascular inva-
sion in tumors between 5 cm and 6.5 cm (55%) was nearly
double the incidence in tumors 5 cm or smaller (31%). (B)
This difference persisted when only solitary tumors were
considered (41% vs. 27%, respectively).
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found at the time of the operation to be invading adja-
cent organs (78% vs. 48%) (P  0.03). Microscopic
vascular invasion was also more prevalent in patients
who had multiple (65%) rather than solitary (44%)
tumors (P  0.05). Even in this subgroup of patients
with large tumors, the incidence of microscopic vascu-
lar invasion increased with increasing size: 5.1 to 6.5
cm, 55%; 6.6 to 10 cm, 58%; 10.1 to 15 cm, 63%;
larger than 15 cm, 76% (P  0.009).
On multivariate analysis, grade, preoperative AFP
level, number of tumor nodules, and tumor size
remained independent predictors of microscopic vascu-
lar invasion (Table 4). Patients with incrementally
larger tumors (hazard ratio [HR]  1.5, 95% conﬁ-
dence interval  1.3-1.8, P  0.001) and high-grade
tumors (HR 1.7, 95% conﬁdence interval 1.3-2.2,
P 0.006) had an increased risk of microscopic vascu-
lar invasion. An AFP level of at least 1000 ng/mL
(HR  2.1, 95% conﬁdence interval  1.5-2.6, P 
0.011) and the presence of multiple tumors (HR 1.8,
95% conﬁdence interval 1.3-2.5, P 0.03) were also
associated with microscopic vascular invasion.
Discussion
Careful allocation of organs has been a guiding princi-
ple in transplantation to optimize beneﬁts to patients
who undergo transplantation and to avoid transplant-
ing patients unlikely to derive a beneﬁt from the treat-
ment. Tumor size is an important predictor of outcome
after surgical treatment for HCC most likely because
tumor size acts as surrogate marker for the presence of
microscopic vascular invasion.12,14 Although several
factors may contribute to a poor prognosis after liver
transplantation, vascular invasion is one of the most
important.1,8,13,14,26,27 While major vascular invasion
can be identiﬁed preoperatively in the majority of cases,
microscopic vascular invasion is impossible to rule out
before transplantation. Although tumor size can be
identiﬁed preoperatively, the use of tumor size alone to
prioritize patients for transplantation is problematic, as
survival after resection of T1 tumors greater than 10 cm
in size is not signiﬁcantly different than survival after
resection of small T1 tumors.1 Thus, recognition of
surrogate markers of microscopic vascular invasion that
can be obtained in the preoperative/pretransplant set-
ting could improve selection of patients for surgical
treatment of larger HCCs, possibly even expanding the
pool of patients most likely to beneﬁt from transplan-
tation despite the presence of large tumors.
Although increasing tumor size is believed to be
associated with microscopic vascular invasion, only a
few studies have examined in detail whether there is a
correlation between tumor diameter and vascular inva-
sion.12,14 In the current study, we showed deﬁnitively
that the frequency of microscopic vascular invasion dra-
matically increased as tumor size increased (Fig. 1). In
fact, the incidence of microscopic vascular invasion was
almost twice as high in tumors larger than 5 cm (61%)
as in smaller tumors (32%) and continued to increase
with increased size even larger than 10 cm. More than
half (55%) of patients with tumors 5.1 to 6.5 cm in size
had microscopic vascular invasion on ﬁnal pathologic
examination. Importantly, the incidence of vascular
invasion in solitary tumors 5.1 to 6.5 cm (41%) was
signiﬁcantly greater than the incidence in solitary
tumors less than 5 cm (27%). Although tumor size was
based on pathologic assessment, current imaging tech-
niques allow for the accurate preoperative determina-
tion of tumor size. Recognition of the relationship
between tumor size and vascular invasion and consid-
eration of the substantially higher incidence of vascular
invasion in larger tumors may be an important factor in
Table 3. Association between Microscopic Vascular
Invasion and Grade in Patients with Tumors Larger than
5 cm Without Evidence of Major Vascular Invasion
(n  502)
Microscopic
Vascular Invasion
Tumor Grade
Low, %
(n)
Intermediate, %
(n)
High, %
(n)
Absent (n  215) 73 (45)* 38 (78) 39 (92)
Present (n  287) 27 (17) 62 (126) 61 (144)*
* P  0.001.
Table 4. Factors Predictive of Microscopic Vascular
Invasion in Patients with Tumors Larger than 5 cm
Without Evidence of Major Vascular Invasion: Multivariate
Analysis (n  502)
Prognostic Factor
Hazard
Ratio 95% CI
P
Value
High-grade tumor 1.7 1.3–2.2 0.006
Large tumor size 1.5 1.3–1.8 0.001
AFP  1000 ng/mL 2.1 1.5–2.6 0.011
Multiple tumors 1.8 1.3–2.5 0.03
Tumor invasion into
adjacent organ 1.1 0.70–1.5 0.22
Abbreviations: CI, conﬁdence interval; AFP, alpha-fetopro-
tein.
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clinical decision-making and treatment selection for
resection and/or allocation of organs for transplanta-
tion.
Tumor grade has been shown to inﬂuence survival
after resection for HCC.14-16,28,29 Data in the trans-
plantation literature suggest that patients with poorly
differentiated large HCC do worse than patients with
moderately- or well-differentiated tumors.14,30 In the
current study, tumor size was a signiﬁcant predictor of
advanced tumor grade. Almost half (47%) of the
patients with tumors larger than 5 cm had a high histo-
logic grade.
Similar to the ﬁndings in the current study, propo-
nents of the University of California San Francisco cri-
teria noted a higher incidence of vascular invasion and
high-grade lesions in patients with tumors larger than
those permitted by the Milan criteria.31 Although no
survival difference between the groups selected using
the Milan vs. University of California San Francisco
criteria was noted in the study by Yao et al.,31 the
median follow-up time was short (only 2 years), and the
conclusions were based on actuarial, rather than actual,
survival data. Because transplantation in patients with
larger tumors may result in signiﬁcantly shorter disease-
free and overall survival, further studies with longer
follow-up are needed before the universal adoption of
an increased size limit for liver transplantation.
Tumor size alone may not be a contraindication to
transplantation. Roayaie et al.32 reported recurrence-
free survival rates of greater than 80% for patients with
tumors larger than 5 cm with no pathologic evidence of
vascular invasion. This ﬁnding is consistent with other
reports of excellent survival after resection of any size
T1 tumor.1 Patients with vascular invasion, however,
were signiﬁcantly more likely to have recurrence and
had a worse overall survival.1,32 These ﬁndings under-
score the fact that vascular invasion, rather than tumor
size, ultimately dictates prognosis.
In the current study, we identiﬁed speciﬁc factors
that help identify the cohort of patients with tumors
larger than 5 cm who are at a higher risk for vascular
invasion. Speciﬁcally, microscopic vascular invasion
was signiﬁcantly more common in patients with high-
grade tumors, an elevated AFP level, or multiple
tumors. These data suggest that rather than using size
alone as a strict selection criterion, biologic parameters
such as grade, AFP level, and multicentricity should be
considered. In particular, when patients with tumors
larger than 5 cm are considered for liver transplanta-
tion, it must be recognized that the histologic grade of
the tumor is the most powerful predictor of occult
vascular invasion (HR 3.66).
Percutaneous ﬁne-needle aspiration (FNA) biopsy
can be an accurate way to preoperatively characterize
HCC grade. The risks of FNA can be minimized at
specialized centers that routinely perform this proce-
dure using appropriate techniques.33 Durand et al.34
reported that the sensitivity and accuracy of FNA
biopsy were 90% and 91%, respectively. The incidence
of needle tract seeding was 1.6%, and no recurrence was
observed after local excision.34 The utility of FNA,
however, remains controversial as the heterogeneity of
histologic grade within a single tumor may limit the
overall accuracy of FNA. Despite this, some centers15
are currently using preoperative FNA tumor grading as
the major criterion to establish whether a patient with
HCC is ﬁt for transplantation and are not considering
tumor size and number of nodules as absolute selection
criteria. Using well- or moderately-differentiated histo-
logic grade as the main selection criteria, Cillo et al.15
reported a 5-year actuarial survival rate of 75% and a
recurrence-free survival rate of 92%. FNA tumor grading
may have a lesser impact on selection for resection in
patients with large HCC, as organ allocation is not an
issue.
In conclusion, to optimize the use of surgical treat-
ments for HCC, current selection based on morpho-
logic criteria of size and number of tumors alone may
need to be modiﬁed to correctly identify patients who
are most likely to beneﬁt from resection or transplanta-
tion. The emphasis on increasing the upper limit of
tumor size while ignoring other biologic parameters
such as grade warrants further scrutiny. Data from this
study as well as others14 suggest that vascular invasion is
predicted by additional factors beyond tumor size, such
as higher preoperative AFP level, multicentricity, and
most importantly, high histologic grade. Based on the
cumulative data, liver transplantation for HCC larger
than 5 cm may therefore be most appropriate for
patients with a low AFP level, solitary tumors, and low
tumor grade. The role of percutaneous biopsy for grad-
ing prior to resection or transplantation requires study,
particularly given the ﬁnding that grade was the most
powerful predictor of occult vascular invasion. Careful
consideration of existing data from large series such as
this may help to guide future studies aimed at expand-
ing criteria for surgical resection and transplantation of
HCC.
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